Email This Article
Headlines & Perspectives
Amylin, Eli Lilly See No Rise In Byetta Heart Risk
By
The Associated Press
06/09/09 - 12:38 PM EDT
Amylin Pharmaceuticals, Eli Lilly cite data showing no elevated heart risk in Byetta patients
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,318.01 | 1,100.56 | 2,204.80 | 35.33 |
Oil *
74.15
|
|
UP
9.75
|
UP
4.49
|
UP
24.75
|
UP
0.46
|
10 Yr
3.53%
SPDR Gold
108.95
|
|
+0.09%
|
+0.41%
|
+1.14%
|
+1.32%
|
Data delayed 20 minutes |
Connect with TheStreet